Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04248101
Other study ID # Umbilical Granuloma
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date July 1, 2016
Est. completion date July 1, 2017

Study information

Verified date January 2020
Source Shaheed Zulfiqar Ali Bhutto Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To study and compare the efficacy and safety of Double Ligation and Topical Silver Nitrate Solution while treating children with Umbilical Granulomas


Description:

The patients underwent one treatment option and then followed up for three weeks and the results noted in terms of success/failure and complications specific to each treatment option and analysed accordingly


Recruitment information / eligibility

Status Completed
Enrollment 176
Est. completion date July 1, 2017
Est. primary completion date June 30, 2017
Accepts healthy volunteers No
Gender All
Age group N/A to 12 Months
Eligibility Inclusion Criteria:

1. Patients of Umbilical Granuloma, less than 1 year age

Exclusion Criteria:

1. Patients who already had any treatment

2. Parents refused to give consent for enrollment

3. Patients lost in follow up

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Double Ligation

Drug:
Topical Silver Nitrate


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Shaheed Zulfiqar Ali Bhutto Medical University

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of Success/Failure of treatment The effect of treatment was noted in a structured proforma on weekly basis for 3 weeks.
Treatment was considered successful if, on local examination the granuloma disappeared completely and did not reappear during the follow up period.
And if the granuloma did not disppear completely during the follow up period after double ligation or application of silver nitrate, treatment was considered to have failed.
These variables were measured as frequency and percentages. The results were compared between the two groups using chi-square test. A significance level of <0.05 was considered significant.
3 weeks
Primary Frequency of complications in both groups The complications were also noted in the above mentioned proforma during the follow up period on weekly basis for 3 weeks.
Complications relevant to the treatment i.e. infection, bleeding, chemical burns and skin discoloration were noted during local examination.
These variables were measured as frequency and percentages. The results were compared between the two groups using chi-square test. A significance level of <0.05 was considered significant
3 weeks
See also
  Status Clinical Trial Phase
Completed NCT06363539 - Silver Nitrate Versus Topical Steroid For Umbilical Granuloma Phase 2
Completed NCT05545462 - Comparison Of Doxycycline And Common Salt For Treatment Of Umbilical Granuloma: A Randomised Control Trial N/A
Completed NCT01662765 - Conservative Versus Surgical Treatment of Umbilical Pilonidal Disease N/A